Gastritis – Pipeline Review, H1 2012

Global Markets Direct
May 28, 2012
33 Pages - SKU: GMD3913769
Legionella Control (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
Plimsoll’s UK Legionella Control (UK) analysis is the most definitive and accurate study of the UK Legionella Control (UK) sector in 2014. The report is split into two sections and uses both a written and graphical  |  read more...
USD 560
Biotechnology (Pharmaceuticals) (Global) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
Plimsoll’s Biotechnology (UK) analysis is the most definitive and accurate study of the Biotechnology (UK) sector in 2014. The report is split into two sections and uses both a written and graphical analysis – analysing the  |  read more...
USD 1,520
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023
10/7/2014 | published by: GlobalData
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023 Summary Allergic conjunctivitis is an inflammation of the eye resulting from an allergic reaction to allergy causing substances (external antigens) like pollen, dander, mold, or other substances. In  |  read more...
USD 3,995
Digestive Remedies in Uzbekistan
10/16/2014 | published by: Euromonitor International
Digestive Remedies in Uzbekistan Digestive remedies benefited strongly from many low-income consumers trading up from home-made remedies at the end of the review period. This was due to rising disposable income levels, which enabled more consumers  |  read more...
USD 900
KOL Insight: Multiple Sclerosis
10/6/2014 | published by: FirstWord
Introduction Recent launches of oral therapies have brought clinical advantages and clear patient benefits and are set to transform the treatment of Multiple Sclerosis (MS). The question is, which products will  |  read more...
USD 6,495
EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023
10/15/2014 | published by: GlobalData
Wind Power in Australia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary Wind Power in Australia, Market Outlook to 2025, Update 2014 - Capacity,  |  read more...
USD 3,995
Myocardial Ischemia Global Clinical Trials Review, H2, 2014
9/21/2014 | published by: GlobalData
Myocardial Ischemia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Myocardial Ischemia Global Clinical Trials Review, H2, 2014 provides data on the Myocardial Ischemia clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H2 2014’, provides an overview of the Waldenstrom Macroglobulinemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Waldenstrom  |  read more...
USD 2,000
Secondary Hyperparathyroidism - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
Secondary Hyperparathyroidism - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Secondary Hyperparathyroidism - Pipeline Review, H2 2014’, provides an overview of the Secondary Hyperparathyroidism’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Secondary  |  read more...
USD 2,000
Cardiac Fibrosis - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
Cardiac Fibrosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cardiac Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Cardiac Fibrosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cardiac  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 500  
    Site License  USD 1,000  
    Global Site License  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!